Main Article Content

Abstract

The purpose of this study is to prove the differential effect of administering the mangosteen Rind extract due to lowering the blood sugar levels of Winstar white male rats induced by streptozotosin (STZ). This study used a randomized design of the ramdomized posttest only control group design. The sample consisted of 4 groups with a sample size of 7 animals each group of rats. All samples were prepared STZ induction of diabetes with a single dose of 50 mg/Kg BW through intraperitoneal (IP). K0 (control group; given 1% CMC 1 cc/day), K1 (treatment group 1; given 0,054 mg glimepiride/200 grBW, K2 (treatment group 2; given mangosteen Rind extract 50 mg/Kg BW), K3 (treatment group 3; given the mangosteen Rind extract 100 mg/Kg BW). Timing of therapy in each group was for 7 days. Shapiro-Wilk normality test (a=0.05) in the BW D variable data, pre-post STZ GDP and D GDP. Testing homogeneity used Levene's test. When data distribution was normal and homogenous, it used an ANOVA deferential test. When data distribution was normal and inhomogeneous, it proceed to apply T-test with 2 free samples. The results: 1) There were significant differences between K0 D GDP with K1 (p=0.015), K0 to K2 (p=0.003) and group K0 to K3 (p=0.002), 2) Whereas no difference was shown in the K1 with K2 (p=0.442), K1 to K3 (p=0,401) and K2 to K3 (p=0.878). Conclusion: The administration of mangosteen Rind extract doses of 50 and 100 mg/kg bw/day did not differ in lowering blood sugar levels compared with glimepiride administration of a dose of 0.054 mg/200 grBW rat/day. Mangosteen Rind extract dose of 100 mg/kg bw/day and 50 mg/kg bw/day did not provide a significant difference in lowering blood sugar levels.

Keywords

Rind extract of mangosteen pericarp (Garcinia mangostana L.) STZ diabetes mellitus blood sugar levels

Article Details

How to Cite
As’ari, H., & Mahartini, D. M. (2017). THE EFFECT OF ADMINISTERING MANGOSTEEN RIND EXTRACT (Garnicia mangostana l) COMPARED WITH GLIMEPIRIDE TO THE BLOOD SUGAR LEVELS OF WHITE MALE RAT (Rattus norwegicus l) INDUCED BY STREPTOZOTOCIN. Folia Medica Indonesiana, 52(4), 241–245. https://doi.org/10.20473/fmi.v52i4.5469

References

  1. Alberti KG and Zimmet PZ (1998). Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15, 539-553
  2. Brosius F (2003). Low dose streptozotocin induction protocol (mouse). Available from https://www.diacomp.org/shared/showProtocol.aspx?id=19. Accessed June 12, 2015
  3. Cattopadhyay RR and Bandyopadhyay M (2005). Effect of Azadirachta indica leaf extract om serum lipid profile changes in normal and streptozotosin induced diabetic rats. African Journal of Biomedical Research 8, 101-104
  4. Cazarolli LH, Zanatta L, Alberton EH, Reis Figueiredo MS, Folador P, Damazio RG, Pizzolatti MG, Mena Barreto Silva FR (2008). Flavonoids: cellular and molecular mechanism of action in glucose homeostasis. Mini reviews in medicinal chemistry 8, 1032-1038
  5. Dalimartha S and Dalimartha FA (2012). Makanan dan Herbal Untuk Penderita Diabetes Mellitus, Jakarta, Penebar Swadaya, p 5-91
  6. Guyton AC and Hall JE (2007). Buku Ajar Fisiologi Kedokteran, Jakarta, EGC, p 699-709
  7. Hanafiah KA (2003). Rancangan Percobaan, Teori & Aplikasi, Jakarta, PT Raja Grafindo Persada Jakarta, p 89-104
  8. Hartanto BS (2011). Mengobati Kanker dengan Manggis, Yogyakarta, Second Hope, p 24
  9. Hong SH, Heo JI, Kim JH, Kwon SO, Yeo KM, Bakowska-barczak AM, Kolodziejczyk P, Ryu OH, Choi MK, Kang YH, Lim SS, Suh HW, Huh SO, Lee JY (2013). Antidiabetic and beta cell-protection activities of purple corn anthocyanins. Biomol Ther (Seoul) 21, 284-289
  10. Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci A, et al (2000). Harrison's Principles of Internal Medicine, Vol III, Bahasa edition by Asdie, Jakarta, EGC, p 2196 - 2201
  11. Jakus V (2000). The role of free radicals, oxidative stress and antioxidant systems in diabetic vascular disease. Bratisl Lek Listy 101, 541-551
  12. Jung HA, Su BN, Keller WJ, Mehta RG, Kinghorn AD (2006). Antioxidant xanthones from the pericarp of Garcinia mangostana (Mangosteen). Journal of Agricultural and Food Chemistry 54, 2077-2082
  13. Kristenses L (2005). Secrets of The Natural Health Benefits of Xanthones from Mangosteen Fruit. Available from http://.Laurie-Info.here.ws(SECURED) Adobe Reader. Accessed February 26, 2014
  14. Lenzen S (2008). The mechanisms of alloxan and streptozotosin-induced diabetes. Diabetologia 51, 216-226
  15. Liu X, Kim JK, Li Y, Liu F, Chen X (2005). Tannic acid stimulates glucose transport and inhibits adipocyte differentiation in 3T3-L1 cells. J Nutr 135, 165–171
  16. Moongkarndi P, Kosem N, Kaslungka S, Luanratana O, Pongpan N, Neungton N (2004). Antiproliferation, antioxidation and induction of apoptosis by Garcinia mangostana (mangosteen) on SKBR3 human breast cancer cell line. J Ethnopharmacol 90, 161-166
  17. Soegondo S, Soewondo P, Subekti I (2009). Penatalaksanaan Diabetes Mellitus Terpadu, 2nd ed, Jakarta, Balai Penerbit Fakultas Kedokteran Universitas Indonesia, p 3-5
  18. Suyatna and Handoko T (2005). Farmakologi dan Terapi, 4th ed, Jakarta, Bagian Farmakologi Fakultas Kedokteran Universitas Indonesia, p 370 – 373
  19. Szkudelski T (2001). The mechanism of alloxan and streptozotosin action in B cells of the rat pancreas. Physiological Research 50, 537-546
  20. Tambunan RM (1998). Telaah kandungan dan aktivitas antimikroba kulit buah manggis (Garcinia mangostan L).Thesis. Institute Teknologi Bandung, Bandung, p 40
  21. Weecharangsan W, Opanasopit P, Sukma M, Ngawhirunpat T, Sotanaphun U, Siripong P (2006). Antioxidative and neuroprotective activities of extracts from the fruit hull of mangosteen (Garcinia mangostan Linn). Medical Principles and Practice 15, 281-287
  22. WHO (2006). Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia. Geneva: World Health Organization. Available from http://www.who.int/diabetes/publications/Definition%20and%20diagnosis%20of%20diabetes_new.pdf. Accessed March 26, 2014
  23. Widowati W (2010). Potensi antioksidan sebagai antidiabetes. Jurnal Kedokteran Maranatha 7
  24. Wild S, Roglic G, Green A, Sicree R, King H (2004). Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27, 1047-1053